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Abstract
Background
High body mass index (BMI) is associated with mortality, but the pervasive problem of con-
founding and reverse causality in observational studies limits inference about the direction
and magnitude of causal effects. We aimed to obtain estimates of the causal association of
BMI with all-cause and cause-specific mortality.
Methods and findings
In a record-linked, intergenerational prospective study from the general population of Swe-
den, we used two-sample instrumental variable (IV) analysis with data from 996,898 fathers
(282,407 deaths) and 1,013,083 mothers (153,043 deaths) and their sons followed up from
January 1, 1961, until December 31, 2004. Sons’ BMI was used as the instrument for
parents’ BMI to compute hazard ratios (HRs) for risk of mortality per standard deviation (SD)
higher parents’ BMI. Using offspring exposure as an instrument for parents’ exposure is
unlikely to be affected by reverse causality (an important source of bias in this context) and
reduces confounding. IV analyses supported causal associations between higher BMI and
greater risk of all-cause mortality (HR [95% confidence interval (CI)] per SD higher fathers’
BMI: 1.29 [1.26–1.31] and mothers’ BMI: 1.39 [1.35–1.42]) and overall cancer mortality (HR
per SD higher fathers’ BMI: 1.20 [1.16–1.24] and mothers’ BMI: 1.29 [1.24–1.34]), including
9 site-specific cancers in men (bladder, colorectum, gallbladder, kidney, liver, lung, lym-
phatic system, pancreas, and stomach) and 11 site-specific cancers in women (gallbladder,
kidney, liver, lung, lymphatic system, ovaries, pancreas, stomach, uterus, cervix, and endo-
metrium). There was evidence supporting causal associations between higher BMI in moth-
ers and greater risk of mortality from kidney disease (HR: 2.17 [1.68–2.81]) and lower risk of
mortality from suicide (HR: 0.77 [0.65–0.90]). In both sexes, there was evidence supporting
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causal associations between higher BMI and mortality from cardiovascular diseases
(CVDs), stroke, diabetes, and respiratory diseases. We were unable to test the association
between sons’ and mothers’ BMIs (as mothers’ data were unavailable) or whether the instru-
ment was independent of unmeasured or residual confounding; however, the associations
between parents’ mortality and sons’ BMI were negligibly influenced by adjustment for avail-
able confounders.
Conclusions
Consistent with previous large-scale meta-analyses and reviews, results supported the
causal role of higher BMI in increasing the risk of several common causes of death, including
cancers with increasing global incidence. We also found positive effects of BMI on mortality
from respiratory disease, prostate cancer, and lung cancer, which has been inconsistently
reported in the literature, suggesting that the causal role of higher BMI in mortality from
these diseases may be underestimated. Furthermore, we expect different patterns of bias in
the current observational and IV analyses; therefore, the similarities between our findings
from both methods increases confidence in the results. These findings support efforts to
understand the mechanisms underpinning these effects to inform targeted interventions and
develop population-based strategies to reduce rising obesity levels for disease prevention.
Author summary
Why was this study done?
• Whilst high body mass index (BMI) clearly increases the risk of mortality, there have
been inconsistencies in the literature, which mainly rely on observational epidemiologi-
cal studies that are limited in their ability to draw causal inferences.
• To overcome the pervasive problem of confounding and reverse causation in such stud-
ies, we aimed to obtain more reliable causal estimates of the association of BMI and
both all-cause and cause-specific mortality using two-sample instrumental variable (IV)
analyses.
What did the researchers do and find?
• In a large, record-linked, intergenerational prospective study comprising data from the
general population of Sweden from 996,898 fathers (282,407 deaths) and 1,013,082
mothers (153,043 deaths) and their sons, we used sons’ BMI as an instrument for
parents’ BMI to compute hazard ratios (HRs) for the risk of mortality per standard devi-
ation (SD) higher parents’ BMI.
• IV analyses supported the causal role of higher BMI and greater risk of all-cause mortal-
ity and mortality from cardiovascular diseases (CVDs), stroke, diabetes, respiratory dis-
eases, and cancer, the latter including 9 site-specific cancers in men (bladder,
colorectum, gallbladder, kidney, liver, lung, lymphatic system, pancreas, and stomach)
and 11 site-specific cancers in women (gallbladder, kidney, liver, lung, lymphatic sys-
tem, ovaries, pancreas, stomach, uterus, cervix, and endometrium).
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• There was also evidence supporting a causal association between higher BMI in mothers
and greater risk of mortality from kidney disease and lower risk of mortality from
suicide.
What do these findings mean?
• For cancer-specific mortality, many IV-derived effect estimates were in the same direc-
tion and of greater magnitude as those derived from previous large-scale meta-analyses
and reviews focusing on both mortality outcomes and the development of specific
cancers.
• Results also implied a positive effect of BMI on mortality from respiratory disease, pros-
tate cancer, and lung cancer, which has been inconsistently reported in the literature,
suggesting that the causal role of higher BMI in mortality from these diseases may be
underestimated.
• These results support efforts to reduce obesity levels for disease prevention, particularly
cancer.
Introduction
The prevalence of obesity is rising [1–3], and severe obesity (body mass index [BMI]�35 kg/
m2) is associated with a greater risk of death [4–7]. However, the magnitude of this relation-
ship over the range of BMI, whether or not higher BMI is a causal determinant of both risk
and progression of several cancers [8–10] or could protect against some diseases (i.e., cancers
of the lung [11,12] and prostate [8,13] and respiratory diseases [4]) is debated [5,14,15]. A sys-
tematic review concluded that, relative to normal weight (18.5–24.9 kg/m2), the risk of all-
cause mortality was greater with severe obesity, but overweight (25.0–29.9 kg/m2) was protec-
tive and moderate obesity (30–34.5 kg/m2) did not alter mortality risk (suggesting a ‘J-shaped’
association) [14]. If mortality is elevated at only very high BMI, rather than in a linear fashion,
this would undermine public health efforts aimed at shifting the entire BMI distribution
downwards to reduce the adverse consequences of obesity [16].
There are at least 2 important alternative explanations of this observed J-shaped association:
(i) confounding by lifestyle and/or behavioural factors, such as smoking (i.e., smokers tend to
be leaner and have higher mortality than nonsmokers); and (ii) reverse causality (i.e., people
losing weight due to existing [and potentially undiagnosed and/or undetected] illness) [17–
19]. These effects could generate spurious positive associations of normal (or under-) weight
with mortality or mask effects of moderate obesity. Excluding or adjusting for confounding
factors and removal of deaths occurring in the first years of follow-up are attempts to over-
come such limitations [20]. Indeed, excluding ever-smokers and those who died during the
first 4 years of follow-up generated a linear positive relationship between BMI and all-cause
mortality risk, with the lowest mortality at BMI<19 kg/m2 [15]. In another study of 1.46 mil-
lion never-smokers with>10-years follow-up (not included in the aforementioned review
[14]), the lowest mortality risk was observed in the recommended normal BMI range [5].
Despite this, measurement error and unmeasured factors can still lead to residual confounding
[21] and biased estimations [22,23]. To compound the confusing observational literature, a
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recent United States–based study observed lower all-cause mortality risk in people who were
overweight, but not obese, versus normal weight, even in never-smokers or those with stable
weight during follow-up (i.e., excluding those with weight loss caused by illness) [24].
Instrumental variable (IV) analysis aims to overcomes biases inherent in observational epi-
demiology and hence improve assessment of causality [25,26]. One application of IV analyses
is the use of offspring exposures as ‘instruments’ for parents’ exposures, for which we and oth-
ers have provided justification [20,23,27–29]. Whilst offspring exposures may not be indepen-
dent of confounding factors, they are robustly related to parents’ own exposures and only
affect the outcome (here, parental mortality) via the parental exposure of which they are acting
as proxies (i.e., likely protected against reverse causality). We conducted a record-linked, inter-
generational prospective cohort study based on a large-scale Swedish cohort. We analysed data
using IV analysis, in which sons’ BMI was used as a proxy for parents’ BMI to provide unbi-
ased causal estimates of the association between parents’ BMI and all-cause and cause-specific
mortality.
Methods
Study population and data linkage
The Swedish Multi-Generation Register was used to identify all boys born in Sweden in 1951
through 1980 and their biological parents, using the unique identity numbers (IDs) given to all
citizens and individuals with permanent permission to live in Sweden [20,28]. Sons’ IDs were
used to obtain their height and weight, which were measured at conscription examinations
between September 1969 and December 2001, at a mean age of 18 years (range 16–25). Fathers
also underwent conscription examinations for height and weight between September 1, 1969
and May 1, 1991. Father–son pairs were defined using these conscription records and Multi-
Generation Register, which included the unique national IDs for each son and his biological
parents. The parents’ IDs were matched to the Swedish Cause of Death Register, providing
dates and causes of parents’ deaths between January 1, 1961 and December 31, 2004. The
underlying cause of death was recorded by the international classification of diseases (ICD;
versions 7–10) codes on death certificates (S1 Table). The study was approved by the Research
Ethics Committee of the University of Bristol Faculty of Health Sciences. For details on study
population, data linkage, and measurements, see S1 Text.
Statistical analysis
Our a priori analysis plan was to repeat our previously published study using extended follow-
up and the more powerful IV methods applied in our subsequent studies [20,30] (see S1 Text).
The distributions of fathers’ and sons’ BMI, height, and smoking, and parents’ ages, education,
and occupational socioeconomic index (SEI) were examined in groups defined by quintiles of
the sons’ or fathers’ BMI through logistic or linear regression, as appropriate. These analyses
used all sons available in the analysis of either parent.
Conventional Cox proportional hazards regression. Within a subset of father–son pairs
in which fathers also had data on BMI, conscription office and dates of birth, and examination,
Cox proportional hazards regression models were used to estimate conventional hazard ratios
(HRs) for all-cause and cause-specific mortality per standard deviation (SD; 2.90 kg/m2) of
fathers’ BMI. Each father’s age was the time axis; models were thus adjusted for fathers’ ages.
These and all subsequent models were conducted with and without adjustment for parents’
educational and occupational SEI and were restricted to those conditions responsible for >40
deaths.
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IV analysis. Within the same subset of data, we performed a conventional one-sample IV
analysis using the ratio method by estimating (i) the HR of all-cause and cause-specific deaths
per SD of sons’ BMI (2.90 kg/m2) using Cox proportional hazards regression (numerator) and
(ii) the association between fathers’ and sons’ BMI (denominator). The causal HR per SD of
fathers’ BMI was derived by exponentiating the ratio between the natural logarithm of the HR
from (i) and the mean difference from (ii), using the same adjustments. Confidence intervals
(CIs) were calculated using Taylor series expansions. Instrument strength was assessed using
the F-statistic of the denominator. The HRs per SD of fathers’ BMI from the conventional Cox
regression were compared with the corresponding HRs from the IV ratio method by applying
a Durbin–Wu–Hausman test to the log(HR) and their standard errors. We also generated
alternative IV estimates using Poisson regression within strata of fathers’ ages and Stata’s qvf
command (S1 Text).
We generated two-sample IV estimates of the HR per SD of fathers’ BMI using the same
ratio method and sons’ BMI as the instrument using all available data for the numerator (i.e.,
not within the subset of data in which all information on sons’ and fathers’ BMI and mortality
was available) [25,26].
Finally, with the additional assumption that the mother–son BMI association was equiva-
lent to the father–son BMI association, we used the same two-sample methodology (as
described above) to estimate the HR per SD of mothers’ BMI (using sons’ BMI as an instru-
ment), even though mothers’ BMI was not measured. After restricting the data to those sons
used in the analysis of both their parents’ mortality, we used 1,000 bootstrap resamples to com-
pare the HR for mothers’ and fathers’ mortality per SD of sons’ BMI.
For each mortality outcome, we present HRs per SD of own BMI (i.e., of either fathers or
mothers) from conventional Cox regression and IV analyses using both one- and two-sample
methodology. Whilst one-sample IV analyses allowed the direct comparison with conventional
Cox regression, the two-sample IV analyses used all available data to increase the precision of
causal estimates and can therefore be interpreted as our best causal estimate of the relationship
between BMI and mortality. For completeness and transparency, we also present HRs per SD
of sons’ BMI (i.e., the numerator of the ratio IV estimate). All statistical analyses were per-
formed using Stata 14.2 on a desktop machine and Stata 12.1 on the University of Bristol’s
Blue Crystal high power computing cluster.
Results
Of the 1,629,396 boys identified from the Swedish Multi-Generation Register, the available
sample for current analyses included 996,898 father–son pairs (282,407 deaths) and 1,013,083
mother–son pairs (153,043 deaths) for 1,036,817 different sons and including 973,164 com-
plete trios (Fig 1). Fathers’ BMI was associated with sons’ BMI (regression coefficient: 0.62 kg/
m2 per SD of sons’ BMI; 95% CI: 0.60–0.64). Sons with higher BMI had parents who were less
likely to spend>10 years in full-time education or be in nonmanual employment (Table 1).
Sons with higher BMI were less likely to smoke but had fathers who were more likely to
smoke. Anthropometric variables and smoking were more strongly associated with fathers’
BMI than they were with sons’ BMI, but measured potential socioeconomic confounders were
similarly associated with fathers’ and sons’ BMI (S2 Table and S3 Table).
Within a subset of father–son pairs in which fathers also had data on BMI, conscription
office and dates of birth, and examination, adjusted Cox regression showed that fathers with a
higher BMI had higher mortality risk from all-causes, cardiovascular disease (CVD), coronary
heart disease (CHD), stroke, overall cancer, and cancers of the brain and colorectum. There
was also evidence that fathers with a higher BMI had lower mortality risk from external causes
Body mass index and mortality: Instrumental variable analysis in one million Swedish individuals
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and, specifically, suicide (Table 2). Sons’ BMI was associated with fathers’ BMI (adjusted
regression coefficient: 0.21 kg/m2 per SD of fathers’ BMI; 95% CI: 0.20–0.22; F-statistic = 673.8),
suggesting that sons’ BMI was a strong instrument. Using one-sample IV analyses, the point
estimates for associations of fathers’ BMI with all mortality outcomes were mostly stronger
compared with conventional Cox regression (Table 2). The precision of the effect estimates
was low for some IV analyses, and the Durbin–Wu–Hausman tests did not find strong evi-
dence for a difference. IV estimates using stratified Poisson regression were almost identical to
main analyses (S4 Table).
Using all available data (both for BMI and mortality outcomes in sons and parents), two-
sample IV analyses supported the causal association of higher BMI on greater risk of all-cause
mortality (HR [95% CI] per SD of fathers’ BMI: 1.29 [1.26–1.31]) and mortality from CVD
(HR: 1.47 [1.43–1.51]), CHD (HR: 1.55 [1.50–1.61]), aortic aneurysm (HR: 1.41 [1.23–1.61]),
stroke (HR: 1.22 [1.15–1.31]), diabetes (HR: 2.40 [2.10–2.74]), respiratory diseases (HR: 1.13
[1.04–1.22]), overall cancer (HR: 1.20 [1.16–1.24]), and cancers of the bladder (HR: 1.24
[1.02–1.51]), colorectum (HR: 1.27 [1.14–1.40]), gallbladder (HR: 1.32 [1.02–1.71]), kidney
Fig 1. Path of participants through the study. BMI, body mass index.
https://doi.org/10.1371/journal.pmed.1002868.g001
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(HR: 1.38 [1.18–1.62]), liver (HR: 1.79 [1.47–2.17]), lung (HR: 1.13 [1.05–1.23]), lymphatic
system (HR: 1.20 [1.08–1.34]), pancreas (HR: 1.45 [1.27–1.65]), and stomach (HR: 1.33 [1.17–
1.53]) (Table 3).
Assuming that mother–son and father–son BMI associations were identical, two-sample IV
analyses provided evidence supporting the causal association between higher BMI and greater
risk of maternal all-cause mortality (HR [95% CI] per SD of mothers’ BMI: 1.39 [1.35–1.42])
and mortality from CVD (HR: 1.62 [1.55–1.69]), CHD (HR: 1.85 [1.74–1.97]), aortic aneurysm
(HR: 1.48 [1.16–1.89]), stroke (HR: 1.25 [1.15–1.35]), diabetes (HR: 4.07 [3.48–4.77]), kidney
disease (HR: 2.17 [1.68–2.81]), respiratory disease (HR: 1.45 [1.30–1.62]), overall cancer (HR:
1.29 [1.24–1.34]), and cancers of the gallbladder (HR: 1.63 [1.35–1.96]), kidney (HR: 1.67
[1.36–2.06]), liver (HR: 1.52 [1.18–1.96]), lung (HR: 1.65 [1.48–1.83]), lymphatic system (HR:
1.27 [1.11–1.45]), ovaries (HR: 1.17 [1.02–1.34]), pancreas (HR: 1.39 [1.20–1.61]), stomach
(HR: 1.30 [1.07–1.57]), uterus (HR: 1.52 [1.30–1.77]), cervix (HR: 1.29 [1.04–1.58]), and endo-
metrium (HR: 1.89 [1.38–2.59]), and lower risk of external mortality causes (HR: 0.89 [0.81–
0.98]), specifically suicide (HR: 0.77 [0.65–0.90]) (Table 4). Restricting to sons contributing to
the analysis of both parents made no substantive difference (S5 Table).
Discussion
Principal findings
Our analysis showed that higher BMI is likely to cause a greater risk of mortality from all-
causes, CVDs, stroke, diabetes, respiratory diseases, overall cancer mortality, 9 site-specific
cancers in men (bladder, colorectum, gallbladder, kidney, liver, lung, lymphatic system, pan-
creas, and stomach) and 11 site-specific cancers in women (gallbladder, kidney, liver, lung,
Table 1. Characteristics of the sons and parents according to quintiles of sons’ BMI.
Subject Variable Quintile of sons’ BMI Mean difference or odds ratio (95% CI) N
1st 2nd 3rd 4th 5th
Sons BMIa,b (kg/m2) 18.5 20.2 21.3 22.7 26.2 2.90 (2.90–2.90) 1,036,817
Heighta,b (cm) 179.6 179.4 179.3 179.1 179.0 –0.19 (−0.20 to −0.18) 1,036,817
Smokersb,c (%) 64% 61% 59% 57% 56% 0.91 (0.89–0.93) 29,508
BMIa,b (kg/m2) 20.3 20.9 21.2 21.6 22.2 0.62 (0.60–0.64) 73,982
Heighta,b (cm) 178.4 178.4 178.2 178.2 178.2 –0.09 (−0.13 to −0.05) 74,001
Fathers Date of birtha 1936.4 1935.3 1934.9 1934.9 1935.8 0.003 (−0.02 to 0.03) 1,025,639
Smokersb,c (%) 62% 64% 62% 64% 67% 1.09 (1.06–1.12) 17,254
Age at sons’ birth (years)a 30.5 30.5 30.5 30.5 30.5 –0.003 (−0.02 to 0.01) 1,025,639
Educated>10 yearsc (%) 57% 56% 55% 53% 48% 0.88 (0.88–0.88) 973,704
In nonmanual workc (%) 51% 51% 50% 49% 42% 0.86 (0.86–0.87) 858,447
Mothers Date of birth 1939.4 1938.4 1938.0 1938.0 1939.0 0.05 (0.03–0.07) 1,035,861
Age at sons’ birth (years)a 27.4 27.4 27.4 27.4 27.3 –0.05 (−0.06 to −0.04) 1,035,861
Educated>10 yearsc (%) 56% 55% 55% 53% 50% 0.92 (0.91–0.92) 1,016,365
In nonmanual workc (%) 50% 50% 49% 47% 42% 0.88 (0.88−0.88) 753,046
aContinuous variables are summarised as means in each quintile and linear regression produced mean differences per SD (2.90 kg/m2) of BMI preadjusted for each
son’s age at examination, conscription office, and secular trends (date of birth).
bMeasured at preconscription medical examination. Smoking was only recorded at examinations in 1969 through 1970.
cBinary variables are summarised as percentages in each quintile and logistic regression produced odds ratios per SD (2.90 kg/m2) of BMI preadjusted for each son’s age
at examination, conscription office, and secular trends (date of birth).
Abbreviations: BMI, body mass index; CI, confidence interval; SD, standard deviation
https://doi.org/10.1371/journal.pmed.1002868.t001
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lymphatic system, ovaries, pancreas, stomach, uterus, cervix, and endometrium). In mothers,
there was evidence supporting the causal role of higher BMI on greater risk of mortality from
kidney disease and lowered mortality from suicide. We also found evidence for positive associ-
ations between BMI and risk of mortality from respiratory disease and cancers of the prostate
and lung, which has been inconsistently reported in the literature, suggesting that previous
studies may suffer from confounding and, importantly, that the role of BMI in mortality from
these causes may be underestimated.
Comparison with other studies
Current results for all-cause mortality and mortality from CVDs, stroke, and diabetes are con-
sistent with previous studies [4–7,31,32]. With each 5 kg/m2 higher BMI (i.e., transition
between BMI categories), there was a 5% greater risk (95% CI: 4%–7%) of all-cause mortality
in the largest meta-analysis including >30 million participants and approximately 3.7 million
deaths [32] and, similarly, there was an approximately 40% greater risk of vascular mortality in
>900,000 adults [4]. Scaling our current results for comparison, each 5 kg/m2 higher fathers’
BMI was associated with a 55% greater all-cause mortality risk (95% CI: 49%–59%), 94% great
CVD mortality risk (HR 95% CI: 1.85–2.04) and more than a 2-fold greater CHD mortality
risk (HR 95% CI: 2.01–2.27). Each 5 kg/m2 higher mothers’ BMI was associated with a 76%
greater all-cause mortality risk (95% CI: 68%–83%) and more than a 2-fold greater risk of
CVD (HR 95% CI: 2.13–2.47) and CHD (HR 95% CI: 2.60–3.22) mortality.
Table 2. A comparison of models for estimating associations of fathers’ mortality per SD (2.90 kg/m2) of BMI at conscription (sons’ or own) in the subset of fathers
with BMI data (N = 68,886).
Cause of death Deaths HRa (95% CI) per SD of
own BMI, unadjusted
HRb (95% CI) per SD of
own BMI, adjusted
HRc (95% CI) per SD of
sons’ BMI, adjusted
IV HRd (95% CI) per SD
of own BMI, adjusted
p-Valuee for comparison of
own BMI with IV HR
All cause 2,436 1.08 (1.03–1.13) 1.07 (1.03–1.12) 1.02 (0.99–1.06) 1.10 (0.94–1.29) 0.746
CVD 436 1.36 (1.23–1.49) 1.33 (1.21–1.47) 1.09 (1.01–1.18) 1.52 (1.06–2.19) 0.455
CHD 243 1.43 (1.27–1.62) 1.40 (1.24–1.59) 1.14 (1.04–1.26) 1.90 (1.19–3.02) 0.189
Stroke 89 1.27 (1.02–1.58) 1.25 (1.01–1.55) 1.09 (0.92–1.29) 1.52 (0.69–3.38) 0.614
Respiratory
diseases
42 1.14 (0.81–1.60) 1.11 (0.80–1.55) 0.91 (0.69–1.20) 0.63 (0.17–2.42) 0.397
External causes 1,109 0.88 (0.82–0.95) 0.89 (0.83–0.95) 0.98 (0.93–1.03) 0.92 (0.72–1.18) 0.752
Suicide 495 0.84 (0.75–0.94) 0.85 (0.76–0.95) 0.93 (0.85–1.00) 0.69 (0.47–1.02) 0.272
Cancer 444 1.22 (1.10–1.35) 1.22 (1.10–1.34) 1.04 (0.96–1.13) 1.23 (0.84–1.79) 0.963
Brain cancer 66 1.29 (1.00–1.66) 1.32 (1.03–1.71) 0.94 (0.75–1.18) 0.75 (0.25–2.21) 0.287
Colorectal
cancer
43 1.56 (1.19–2.06) 1.54 (1.17–2.02) 1.07 (0.83–1.37) 1.36 (0.42–4.42) 0.831
Lung cancer 63 1.01 (0.75–1.35) 1.00 (0.75–1.34) 1.00 (0.80–1.24) 0.98 (0.34–2.77) 0.962
Lymphatic
cancer
67 1.25 (0.97–1.61) 1.24 (0.96–1.59) 1.02 (0.83–1.25) 1.09 (0.41–2.92) 0.799
aHR from Cox regression of fathers’ mortality per SD (2.90 kg/m2) of own BMI. Each father’s age was the time axis.
bHR from Cox regression of fathers’ mortality per SD (2.90 kg/m2) of own BMI, adjusted for educational and occupational SEI. Each father’s age was the time axis.
cHR from Cox regression of fathers’ mortality per SD (2.90 kg/m2) of sons’ BMI, adjusted for educational and occupational SEI. Each father’s age was the time axis. This
can be interpreted as the numerator of the ratio estimate for IV analyses.
dHR from a ratio method IV estimate with sons’ BMI as the instrument for fathers’ BMI, adjusted for educational and occupational SEI.
eHR from the conventional analysis of fathers’ BMI were compared with those from the ratio method IV using a Durbin–Wu–Hausman test.
These analyses were all restricted entirely to those fathers with BMI data (N = 68,886) and to conditions causing at least 40 fathers’ deaths within this subset. BMI was
preadjusted for secular trends, conscription office and age at examination.
Abbreviations: BMI, body mass index; CHD, coronary heart disease; CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; IV, instrumental variable;
SD, standard deviation; SEI, socioeconomic index
https://doi.org/10.1371/journal.pmed.1002868.t002
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For cancer-specific mortality, many IV-derived effect estimates were in the same direction
and of greater magnitude as those derived from previous large-scale meta-analyses and reviews
focusing on both mortality outcomes and the development of specific cancers [4–8,31]. For
example, higher BMI has been consistently associated with a greater risk of all-cause mortality
and neoplastic mortality in multiple studies [4,5,32]. Our current results also provided some
evidence for positive associations with the risk of mortality from respiratory disease, prostate
cancer, and lung cancer, which have been inconsistently reported in the literature, suggesting
that such observational results may be spurious, arising from confounding and, importantly,
the role of BMI in mortality from these causes (and likely others) may be underestimated
Table 3. Cox proportional hazards models for fathers’ mortality with BMI (N = 996,898).
Cause of death Deaths HRa (95% CI) per SD of sons’ BMI,
unadjusted
HRb (95% CI) per SD of sons’ BMI,
adjusted
IV HRc (95% CI) per SD of own BMI,
adjusted
All cause 282,407 1.07 (1.07–1.08) 1.05 (1.05–1.06) 1.29 (1.26–1.31)
CVD 127,415 1.10 (1.10–1.11) 1.08 (1.08–1.09) 1.47 (1.43–1.51)
CHD 81,805 1.12 (1.11–1.13) 1.10 (1.09–1.10) 1.55 (1.50–1.61)
Aortic aneurysm 5,002 1.08 (1.05–1.11) 1.07 (1.04–1.11) 1.41 (1.23–1.61)
Stroke 22,022 1.06 (1.04–1.07) 1.04 (1.03–1.06) 1.22 (1.15–1.31)
Diabetes 4,278 1.22 (1.19–1.26) 1.20 (1.17–1.24) 2.40 (2.10–2.74)
Kidney disease 1,996 1.06 (1.01–1.11) 1.04 (1.00–1.09) 1.22 (0.98–1.51)
Respiratory diseases 14,015 1.05 (1.03–1.06) 1.03 (1.01–1.04) 1.13 (1.04–1.22)
External causes 25,651 1.02 (1.01–1.04) 1.00 (0.99–1.01) 0.99 (0.94–1.05)
Suicide 9,564 1.00 (0.98–1.02) 0.98 (0.96–1.00) 0.91 (0.83–1.00)
Cancer 79,393 1.05 (1.04–1.05) 1.04 (1.03–1.05) 1.20 (1.16–1.24)
Bladder cancer 2,475 1.05 (1.01–1.09) 1.05 (1.00–1.09) 1.24 (1.02–1.51)
Brain cancer 3,094 1.01 (0.98–1.05) 1.01 (0.97–1.05) 1.05 (0.89–1.25)
Colorectal cancer 8,929 1.06 (1.03–1.08) 1.05 (1.03–1.07) 1.27 (1.14–1.40)
Gallbladder cancer 1,362 1.07 (1.01–1.13) 1.06 (1.00–1.12) 1.32 (1.02–1.71)
Kidney cancer 3,494 1.08 (1.04–1.12) 1.07 (1.03–1.11) 1.38 (1.18–1.62)
Liver cancer 2,222 1.14 (1.09–1.18) 1.13 (1.08–1.18) 1.79 (1.47–2.17)
Lung cancer 14,636 1.04 (1.03–1.06) 1.03 (1.01–1.04) 1.13 (1.05–1.23)
Lymphatic cancer 8,207 1.05 (1.02–1.07) 1.04 (1.02–1.06) 1.20 (1.08–1.34)
Malignant
melanoma
1,862 0.99 (0.95–1.04) 1.00 (0.95–1.04) 0.98 (0.78–1.23)
Oesophageal cancer 1,727 1.04 (0.99–1.09) 1.03 (0.98–1.08) 1.14 (0.90–1.44)
Prostate cancer 12,712 1.01 (0.99–1.03) 1.01 (0.99–1.03) 1.05 (0.96–1.15)
Pancreatic cancer 5,269 1.09 (1.06–1.12) 1.08 (1.05–1.11) 1.45 (1.27–1.65)
Stomach cancer 4,928 1.08 (1.05–1.11) 1.06 (1.03–1.09) 1.33 (1.17–1.53)
Testicular cancer 206 1.13 (1.00–1.28) 1.10 (0.97–1.25) 1.59 (0.88–2.88)
Thyroid cancer 223 1.01 (0.88–1.16) 1.00 (0.87–1.15) 0.98 (0.51–1.91)
aHR from Cox regression of fathers’ mortality per SD (2.90 kg/m2) of sons’ BMI (N = 996,898). BMI was preadjusted for secular trends, conscription office, and age at
examination. Each father’s age was the time axis. This can be interpreted as the numerator of the ratio estimate for IV analyses.
bHR from Cox regression of fathers’ mortality per SD (2.90 kg/m2) of sons’ BMI (N = 996,898). BMI was preadjusted for secular trends, conscription office, age at
examination, and both educational and occupational SEI. Each father’s age was the time axis. This can be interpreted as the numerator of the ratio estimate for IV
analyses.
cHR from Cox regression of fathers’ mortality per SD (2.90kg/m2) of fathers’ BMI, using a two-sample IV approach with sons’ BMI as the instrument for fathers’ BMI,
adjusted for educational and occupational SEI. The father–son association in BMI was estimated using the subset of data with fathers’ BMI (N = 68,886).
Abbreviations: CHD, coronary heart disease; CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; IV, instrumental variable; SD, standard deviation;
SEI, socioeconomic index
https://doi.org/10.1371/journal.pmed.1002868.t003
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[4,6,33]. Indeed, the current literature is becoming more consistent with regards to the likely
detrimental impact of higher BMI on the risk of aggressive prostate cancer [10]. Additionally,
in the Million Women Study, higher BMI was associated with a greater risk of mortality from
Table 4. Cox proportional hazards models for mothers’ mortality with BMI (N = 1,013,083).
Cause of death Deaths HRa (95% CI) per SD of sons’ BMI,
unadjusted
HRb (95% CI) per SD of sons’ BMI,
adjusted
IV HRc (95% CI) per SD of own BMI,
adjusted
All cause 153,043 1.08 (1.07–1.08) 1.07 (1.07–1.08) 1.39 (1.35–1.42)
CVD 50,931 1.12 (1.11–1.13) 1.11 (1.10–1.12) 1.62 (1.55–1.69)
CHD 24,036 1.16 (1.14–1.17) 1.14 (1.12–1.15) 1.85 (1.74–1.97)
Aortic aneurysm 1,529 1.09 (1.04–1.15) 1.09 (1.03–1.14) 1.48 (1.16–1.89)
Stroke 14,498 1.06 (1.04–1.08) 1.05 (1.03–1.07) 1.25 (1.15–1.35)
Diabetes 2,600 1.37 (1.32–1.41) 1.34 (1.30–1.39) 4.07 (3.48–4.77)
Kidney disease 1,151 1.20 (1.13–1.26) 1.18 (1.11–1.24) 2.17 (1.68–2.81)
Respiratory diseases 7,842 1.09 (1.07–1.12) 1.08 (1.06–1.11) 1.45 (1.30–1.62)
External causes 9,449 0.98 (0.96–1.00) 0.98 (0.96–1.00) 0.89 (0.81–0.98)
Suicide 3,821 0.94 (0.91–0.98) 0.95 (0.91–0.98) 0.77 (0.65–0.90)
Cancer 62,231 1.06 (1.05–1.07) 1.05 (1.05–1.06) 1.29 (1.24–1.34)
Bladder cancer 633 1.08 (1.00–1.17) 1.07 (0.99–1.16) 1.39 (0.95–2.03)
Brain cancer 2,243 1.00 (0.95–1.04) 1.00 (0.96–1.04) 0.99 (0.81–1.22)
Breast cancer 11,429 1.00 (0.98–1.02) 1.00 (0.98–1.02) 1.00 (0.92–1.10)
Breast cancer,
<50 y.o.
2,568 1.00 (0.96–1.04) 1.00 (0.96–1.04) 1.01 (0.84–1.21)
Breast cancer,
�50 y.o.
8,861 1.00 (0.98–1.02) 1.00 (0.98–1.02) 1.00 (0.90–1.12)
Colorectal cancer 6,663 1.02 (1.00–1.05) 1.02 (0.99–1.04) 1.09 (0.97–1.23)
Gallbladder cancer 2,453 1.12 (1.08–1.17) 1.11 (1.06–1.15) 1.63 (1.35–1.96)
Kidney cancer 1,965 1.12 (1.08–1.17) 1.11 (1.07–1.16) 1.67 (1.36–2.06)
Liver cancer 1,359 1.10 (1.05–1.16) 1.09 (1.04–1.15) 1.52 (1.18–1.96)
Lung cancer 7,558 1.12 (1.09–1.14) 1.11 (1.09–1.13) 1.65 (1.48–1.83)
Lymphatic cancer 5,150 1.06 (1.03–1.09) 1.05 (1.02–1.08) 1.27 (1.11–1.45)
Malignant melanoma 1,103 1.04 (0.98–1.11) 1.04 (0.98–1.11) 1.23 (0.92–1.63)
Oesophageal cancer 429 1.07 (0.97–1.18) 1.07 (0.97–1.18) 1.40 (0.88–2.23)
Ovarian cancer 4,971 1.03 (1.01–1.06) 1.03 (1.00–1.06) 1.17 (1.02–1.34)
Pancreatic cancer 4,209 1.08 (1.04–1.11) 1.07 (1.04–1.11) 1.39 (1.20–1.61)
Stomach cancer 2,456 1.07 (1.03–1.11) 1.06 (1.01–1.10) 1.30 (1.07–1.57)
Thyroid cancer 272 1.08 (0.96–1.22) 1.07 (0.95–1.21) 1.39 (0.79–2.47)
Uterine cancer 3,521 1.10 (1.07–1.14) 1.09 (1.06–1.13) 1.52 (1.30–1.77)
Cervical cancer 1,938 1.07 (1.03–1.12) 1.05 (1.01–1.10) 1.29 (1.04–1.58)
Endometrial cancer 834 1.15 (1.08–1.23) 1.14 (1.07–1.22) 1.89 (1.38–2.59)
aHR from Cox regression of mothers’ mortality per SD (2.90 kg/m2) of sons’ BMI (N = 1,013,083). BMI was preadjusted for secular trends, conscription office, and age
at examination. Each mother’s age was the time axis. This can be interpreted as the numerator of the ratio estimate for IV analyses.
bHR from Cox regression of mothers’ mortality per SD (2.90 kg/m2) of sons’ BMI (N = 1,013,083). BMI was preadjusted for secular trends, conscription office, age at
examination, and both educational and occupational SEI. Each mother’s age was the time axis. This can be interpreted as the numerator of the ratio estimate for IV
analyses.
cHR from Cox regression of mothers’ mortality per SD (2.90kg/m2) of mothers’ BMI, using a two-sample IV approach with sons’ BMI as the instrument for mothers’
BMI, adjusted for educational and occupational SEI, assuming that the mother–son association in BMI was equivalent to the father–son association in the subset of data
with fathers’ BMI (N = 68,886).
Abbreviations: CHD, coronary heart disease; CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; IV, instrumental variable; SD, standard deviation;
SEI, socioeconomic index; y.o., years old
https://doi.org/10.1371/journal.pmed.1002868.t004
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cancers of the endometrium, oesophagus, kidney, pancreas, lymphatic system, ovary, post-
menopausal breast, and premenopausal colorectal cancer [6]. It is worth noting that cancers of
the lymphatic system are very heterogeneous with regards to malignancy subtype definition
and evidence supporting the likely impact of BMI on each subtype; therefore, larger studies
that are able to separate cancer subtypes at scale are required to determine the specific impact
of higher BMI on such outcomes [10]. Additionally, whilst it is likely that human papilloma
virus (HPV) infection is the most potent risk factor for cervical cancer and the literature on
BMI as a causal risk factor has been inconsistent, our study supports previous large-scale
cohort studies and meta-analyses that have implicated a potential role of obesity in cervical
cancer risk and mortality [6].
Our results are also consistent with the few studies using Mendelian randomization (MR;
i.e., using genetic variation as IVs [34]) that have interrogated the causal impact of higher BMI
on cancer-specific survival and mortality, which suggested that higher BMI reduced breast
cancer–specific survival and increased prostate cancer mortality [13,35]. Furthermore, the
causal relationship between higher BMI and lower mortality from suicide implied in the cur-
rent analyses is consistent with a previous prospective study in the Nord-Trøndelag Health
Study in Norway, which showed that suicide risk was lower with higher BMI (HR per SD
higher BMI: 0.82; 95% CI: 0.68–0.98) [36]. However, there are inconsistencies in the literature
[37]; therefore, these results should be taken with caution until replicated in prospective stud-
ies with causal methodologies and sample sizes comparable to the current analysis.
Strengths
Our current analyses used comprehensive data from a large-scale, prospective Swedish cohort
of over 1 million adults to assess the likely causal implications of higher BMI on mortality and
extend our previous study of this relationship [20] in a variety of ways: we (i) used complemen-
tary one-sample (i.e., generating an IV estimate directly comparable to conventional Cox
regression in the same data) and two-sample IV methodologies (i.e., increasing the precision
of our causal estimates), rather than only the one-sample approach; (ii) presented HRs of mor-
tality outcomes per unit higher parents’ BMI (as opposed to offspring BMI [20]) for better
interpretation; and (iii) extended follow-up by 3 more years than previously reported, giving
an additional 70,647 parent deaths. This greater sample size not only provided the statistical
power to investigate several cancer subtypes and rarer causes of death with greater precision
than has been done before (in the literature and by our previous efforts [20]) but allowed the
investigation of a more comprehensive set of mortality outcomes, including endometrial, gall-
bladder, oesophageal, pancreatic, thyroid, and rectal cancers and malignant melanoma.
Limitations
We and others have previously described the rationale for believing that using offspring expo-
sure as an instrument for parents’ exposure is appropriate [20,23,27–29]. Whilst we were
unable to test the association between sons’ and mothers’ BMI, most studies have found
parents’ BMI to be strongly and similarly associated with sons’ BMI [38]. We confirmed this
for fathers’ BMI here, implicating that sons’ BMI has good instrument strength. Generally, IV
estimates may be biased if the behavioural, genetic, or socioeconomic factors confounding the
observational association between parents’ BMI and parents’ mortality also influence sons’
BMI. This bias is stronger the weaker the instrument, so instrument strength of sons’ BMI lim-
its the magnitude of this bias. Whilst most of the measured confounding factors were similarly
associated with sons’ and parents’ BMI in this study, the associations between parents’ mortal-
ity and sons’ BMI were reassuringly negligibly influenced by adjustment for available
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confounders in conventional and IV analyses. Although we were unable to test whether the
instrument was independent of unmeasured or residual confounding within this study, some
of these confounding factors (e.g., fathers’ smoking) were more strongly associated with
fathers’ BMI than with sons’ BMI. Therefore, the patterns of association observed between
these confounding factors with parents’ and sons’ BMI were different, suggesting that the con-
ventional and IV analyses are likely differentially biased by these factors. Thus, triangulation
between these two analyses methods with differential biases, which showed similar estimates
of association between BMI and mortality, provides more confidence in these current results
[39]. Furthermore, the inherent correlation between sons’ and parental BMI measures and
likely differences in intergenerational environment would be more likely to reduce bias in
these analyses and, as such, is an improvement to observational measures alone.
We argue that these IV estimates are unlikely to be affected by reverse causality (an impor-
tant source of bias), because a parent’s ill health is unlikely to directly affect their sons’ BMI
[20,23]. It is also unlikely that sons’ BMI could directly affect parents’ mortality [23]. Thus,
whilst the IV methodology used here cannot be considered gold standard for assessing causal-
ity, results add to existing literature within this context.
More broadly, BMI is unable to distinguish fat from lean mass, a property of which has
been suggested to explain why overweight individuals show the lowest risk of mortality [40].
Additionally, these results are applicable only to mortality and not to incidence or progression
of the causes (i.e., cancer or CVD) of mortality analysed and many of the outcomes analyses
are heterogeneous. Therefore, further large studies with accurate measures of body fatness
(e.g., with dual-energy X-ray absorptiometry) and more refined measures of heterogeneous
outcome diagnosis are required to disentangle the mechanisms by which higher BMI causes
greater mortality risk and to provide more specific targets for population-level intervention.
Lastly, given the sample size of complete data currently available (approximately 68,000
father–son pairs, representing fewer than 2,500 deaths), we were unable to analyse the nonlin-
ear relationship between BMI and mortality, for which larger samples are required to fully
understand the pattern of association between BMI and mortality over the full distribution of
BMI.
Conclusions
Higher BMI is likely to cause a greater risk of several common causes of death, including can-
cers of which the global incidence is increasing. We also found positive effects of BMI with
mortality from respiratory disease, and cancers of the prostate and lung, which is inconsis-
tently reported in the literature, suggesting that existing observational studies may suffer from
confounding and, importantly, the role of BMI in mortality from these specific causes may be
underestimated. These findings therefore further support efforts for reducing the rising popu-
lation trends of obesity.
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